Preliminary findings from New Zealand’s first online Drug Trends Survey has found methamphetamine is currently more
available than cannabis, throughout the country.
The study, carried out by researchers from Massey University’s SHORE and Whāriki Research Centre, aimed to measure the availability of alcohol and drugs and demand for help services for substance use problems in all
regions of New Zealand. The first of a series of research bulletins reporting the findings has been released today.
Detailed analysis of the findings will be presented to the Ministry of Health and other government agencies later this
month.
Lead researcher, Associate Professor Chris Wilkins says higher availability of methamphetamine was found in Northland,
Bay of Plenty, Hawke’s Bay, Gisborne, Waikato, Manawatu-Wanganui, West Coast and Southland.
The anonymous online survey, promoted via a targeted Facebook campaign, was conducted from November 2017 to February
2018. A total of 6,100 people completed the survey. Participants were asked a series of questions about the availability
of the drugs they had used in the past six months. Anonymised surveys were carefully reviewed to ensure high quality and
consistent data.
“While there have been anecdotal reports around the country that meth is easier to obtain than cannabis, to date there
had been no data available to verify these claims, or confirm the extent of the issue throughout New Zealand,” Dr
Wilkins says. “These findings suggest a need to further prioritise the focus on meth, rather than on cannabis. This
could include increasing access to help services for substance use problems for people living in the regions.”
Overall, 14 per cent of those who used cannabis described the current availability to be “very easy”, while 54 per cent
of methamphetamine users reported the current availability as “very easy”.
“Only 14 per cent of the cannabis users could purchase cannabis in 20 minutes or less, while 31 per cent of the
methamphetamine users were able to purchase methamphetamine in 20 minutes or less,” he says.
This raises some serious questions concerning the supply of drugs and policy settings in relation to different drugs
types. “Is the higher availability of methamphetamine the result of an intentional strategy by drug dealers who are
seeking to maximise profits by promoting the sale of a more addictive drug type with a higher profit margin? Does the
current supply reduction strategy need to be refocused on methamphetamine rather than cannabis?
“Methamphetamine is widely considered to be the more harmful drug, but cannabis is more vulnerable to routine law
enforcement activity due to the space and time required to cultivate it, and its bulky and distinctive physical
appearance and smell,” Dr Wilkins says.
Higher availability of methamphetamine relative to cannabis was found in all regions. “In Northland, 65 per cent of
users described the current availability of methamphetamine to be ‘very easy’ compared to only 15 per cent for cannabis.
Thirty two percent of the Northland respondents could purchase methamphetamine in 20 minutes or less, compared to only
13 per cent who could purchase cannabis in 20 minutes or less,” Dr Wilkins says.
Regions where lower availability of methamphetamine was found were in Auckland, Taranaki, Wellington,
Nelson/Marlborough, Canterbury and Otago.
The research was carried out by Dr Wilkins, with Jitesh Prasad, Dr Marta Rychert, Dr Jose Romeo and Thomas Graydon-Guy.
The SHORE and Whāriki Research Centre would like to acknowledge the support of the Community Action on Youth and Drugs
(CAYAD) with special thanks to the Te Runanga O Ngai Te Rangi Iwi Trust.